PMID- 23739870 OWN - NLM STAT- MEDLINE DCOM- 20131104 LR - 20211021 IS - 1432-1203 (Electronic) IS - 0340-6717 (Linking) VI - 132 IP - 10 DP - 2013 Oct TI - Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. PG - 1131-9 LID - 10.1007/s00439-013-1320-5 [doi] AB - Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) near the human leukocyte antigen (HLA)-DP loci that were significantly correlated with outcomes of hepatitis B virus (HBV) infection. We performed a case-control study nested in a well-characterized cohort of booster recipients to assess whether genetic variants of HLA-DPB1 are also associated with response to hepatitis B (HB) vaccination. The cases and controls were 171 and 510 booster recipients whose post-booster titers of antibodies against HBV surface antigen (anti-HBs) were undetectable and detectable, respectively. The HLA-DPB1 genotype was determined using sequence-based techniques. The frequencies of HLA-DPB1 alleles were significantly different between cases and controls (p = 1.7 x 10(-8)). The HLA-DPB1 05:01 and 09:01 alleles were significantly more frequent in the cases, and 02:01:02, 02:02, 03:01:01, 04:01:01, and 14:01, were significantly more frequent in the controls. The adjusted odds ratio (OR) of undetectable post-booster anti-HBs titers was significantly correlated with the number of risk alleles (p for trend = 3.8 x 10(-5)). For the number of protective alleles, the trend was significantly inversed (p for trend = 1.3 x 10(-5)). As compared with subjects with two risk alleles, adjusted OR were 0.34 (95 % confidence interval [CI] 0.21-0.55) and 0.20 (95 % CI 0.08-0.48) for subjects with 1 and 2 protective alleles, respectively. The HLA-DPB1 02:02, 04:01:01, 05:01 and 09:01 alleles were also significantly correlated with the likelihoods of undetectable pre-booster anti-HBs titers. Our results indicated that HLA-DPB1 is significantly correlated with response to booster HB vaccination in adolescent who had received postnatal active HB vaccination. HLA-DBP1 may also determine the long-term persistence of response to HB vaccination. FAU - Wu, Tzu-Wei AU - Wu TW AD - Department of Medicine, Mackay Medical College, No. 46, Sec. 3, Jhong-Jheng Rd., San-Jhih Dist., New Taipei City, 252, Taiwan. FAU - Chu, Chen-Chung AU - Chu CC FAU - Ho, Tzu-Ying AU - Ho TY FAU - Chang Liao, Huei-Wen AU - Chang Liao HW FAU - Lin, Sheng-Kai AU - Lin SK FAU - Lin, Marie AU - Lin M FAU - Lin, Hans Hsienhong AU - Lin HH FAU - Wang, Li-Yu AU - Wang LY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130606 PL - Germany TA - Hum Genet JT - Human genetics JID - 7613873 RN - 0 (HLA-DP beta-Chains) RN - 0 (HLA-DPB1 antigen) RN - 0 (Hepatitis B Antibodies) RN - 0 (Hepatitis B Vaccines) SB - IM MH - Adolescent MH - Case-Control Studies MH - Female MH - Gene Frequency MH - Genetic Loci MH - *Genotype MH - HLA-DP beta-Chains/*genetics/metabolism MH - Hepatitis B/prevention & control MH - Hepatitis B Antibodies/immunology MH - Hepatitis B Vaccines/*administration & dosage/*immunology MH - Humans MH - *Immunization, Secondary MH - Male MH - Odds Ratio MH - Risk Factors MH - Vaccination EDAT- 2013/06/07 06:00 MHDA- 2013/11/05 06:00 CRDT- 2013/06/07 06:00 PHST- 2013/03/10 00:00 [received] PHST- 2013/05/26 00:00 [accepted] PHST- 2013/06/07 06:00 [entrez] PHST- 2013/06/07 06:00 [pubmed] PHST- 2013/11/05 06:00 [medline] AID - 10.1007/s00439-013-1320-5 [doi] PST - ppublish SO - Hum Genet. 2013 Oct;132(10):1131-9. doi: 10.1007/s00439-013-1320-5. Epub 2013 Jun 6.